|
|
| May 22 |
A Layman’s Guide to the INVEST Visa |
| May 15 |
NVCA requests FASB for additional time to study the Financial Instruments exposure draft |
| Apr 25 |
NVCA and MedIC Release Patient Capital 3.0 (Report) |
| Apr 18 |
NVCA Supports Immigration Reform in the Senate (Letter to Sen. Bennet, Letter to Gang of 8) |
| Mar 20 |
NVCA Files Amicus Brief on Myriad Case |
| Mar 19 |
NVCA Member Testifies on Health IT 3-19-13 |
| Mar 14 |
NVCA Joins Tech Community in Support of High-Skilled Immigration Reform |
| Mar 5 |
NVCA’s Deepak Kamra Testifies on Immigration Policy Supporting Startup Visa (Testimony and Press Release) |
| Feb 27 |
NVCA/MedIC Comments on FDA Alternative Approval Pathway |
| Jan 29 |
Summary of SBA’s Final Rule on SBIR/STTR |
|
2012 |
| Nov 7 |
NVCA 2012 Election Analysis |
| Nov 1 |
NVCA Comment Letter: Private Company Decision-Making Framework |
| Sept 7 |
FDA 2012 Benefit/Risk Guidance – VC Perspective |
| Sept 7 |
Medical Device Innovation Ecosystem Presentation |
| July 31 |
Energy, Investor and Tech Communities Provide Statement Regarding “No More Solyndras” Act |
| July 16 |
NVCA Submits Comment Letter on SBIR Draft Rule |
| July 12 |
Summary of FDASIA Drug and Device Provisions July 2012 |
| July 9 |
NVCA & MedIC Commend Signing of FDA Safety and Innovation Act |
| May 31 |
NVCA & MedIC Applaud Passage of FDA User Fee Reauthorization Bills |
| May 15 |
NVCA Sends Letter To Congress in Support of Clean Energy Standard |
| Apr 5 |
NVCA Thanks U.S. Congress for Passage of JOBS Act |
| Mar 28 |
Startup Companies Hiring for Technical and Sales Jobs |
| Mar 27 |
Congress Passes JOBS Act – NVCA Thanks Supporters |
| Mar 20 |
JOBS Act Facts |
| Mar 15 |
Associations Support JOBs Act |
| Mar 12 |
700+ Entrepreneurs Urge Senate to Act on IPO On Ramp Legislation (Letter) |
| Mar 8 |
NVCA Applauds House Passage of IPO On Ramp Legislation |
| Mar 6 |
On Ramp Q&A |
| Feb 16 |
NVCA & NYSE Support HR 3606 |
| Feb 15 |
NVCA Comments on Investment Company Criteria (Topic 946) |
| Feb 15 |
NVCA Member Testifies on MDUFA Re-Authorization |
| Feb 6 |
NVCA Submits Comment Letter re “Volker Rule” |
| |
2011 |
| Dec 16 |
NVCA Comments on FAF Proposal for Private Company Financial Reporting |
| Dec 14 |
Kate Mitchell Testifies on IPO Legislation |
| Dec 9 |
NVCA Sends Letters To Congress Supporting SBIR Compromise |
| Dec 7 |
NVCA Voices Opposition To SOPA and PIPA Legislation |
| Dec 1 |
NVCA Statement on Spurring Job Growth Through Capital Formation |
| Nov 23 |
White Paper Guidance on ERA/RIA Filing Pathway |
| Nov 17 |
NVCA Submits Amicus Brief on Prometheus vs. Mayo Clinic Case |
| Nov 16 |
Venture-Backed Startups Looking to Fill Nearly 11,000 Jobs |
| Nov 2 |
Venrock’s Ray Rothrock Testifies On Fostering Innovation |
| Oct 20 |
IPO Task Force Issues Recommendations- (Press Release, Study, and Slide Deck) |
| Oct 10 |
NVCA’s Mark Heesen Discusses Liquidity Challenges on BioCentury 10/9/11 |
| Oct 6 |
MedIC Releases Vital Signs (Press Release and Data Slides) |
| Oct 5 |
NVCA statement on capital market regulatory reforms |
| Sept 27 |
NVCA Member Testifies on Impact of Medical Device and Drug Regulation |
| Sept 14 |
NVCA Members Testify in Support of Startup Visa Legislation (Shervin Pishevar and Jason Mendelson) |
| Sept 12 |
StartUpHire and NVCA Work with the Startup America Partnership to Promote Jobs |
| Sept 1 |
NVCA Letter to Senate Appropriators In Support of ARPA-E Funding – 9/1/11 |
| Aug 1 |
NVCA Letter to FAF Supporting Blue Ribbon Panel Recommendations |
| July 7 |
NVCA Member Jonathan Leff Testifies on Improving FDA Approval Process |
| July 7 |
ARPA-E Letter to Congressional Appropriators |
| July 1 |
NVCA Comments on Medical Device Innovation Initiative |
| June 24 |
NVCA Analysis of SEC VC Definition Ruling |
| June 23 |
NVCA Opposes Patent Reform Fee Diversion |
| June 15 |
NVCA Signs On to Support Funding for ARPA-E |
| June 15 |
NVCA letter on HR 1249, The America Invents Act of 2011 |
| June 6 |
NVCA Board Member Jack Lasersohn Testifies on FDA Reform Priorities |
| May 25 |
NVCA President Testifies Before JEC on Innovation and Job Growth in Life Sciences |
| Apr 15 |
NVCA Comments on Senate Clean Energy Standard |
| Apr 11 |
NVCA Recommendation for Personal Trading Practices |
| Apr 8 |
NVCA and MEDIC FDA Reform Priorities - April 2011 |
| Mar 22 |
US Treasury Access to Capital Conference Presentation |
| Mar 18 |
NVCA Spearheads Grassroots Campaign In Support of ARPA-E |
| Mar 18 |
NVCA Testifies on Energy Policy’s Impact on Investment |
| Mar 3 |
NVCA Expresses Concern Regarding Patent Reform Legislation S. 23 |
| Feb 10 |
NVCA Statement Regarding Medical Device Innovation Initiative |
| Jan 24 |
NVCA Comment Letter to SEC on Implementation Proposal |
| Jan 14 |
NVCA Submits Comments to SEC on VC Definition: Full Comment Letter, Summary, Submission Instructions |
| |
2010 |
| Dec 17 |
NVCA Applauds the Senate Passage of America COMPETES |
| Dec 16 |
NVCA & MedIC Comments on Proposed Parallel Review Process of Medical Products |
| Dec 9 |
Statement by NVCA and TechNet Support Extending Clean Energy Tax Incentives |
| Dec 8 |
NVCA Supports Increasing Offering Limit under SEC Regulation A |
| Nov 18 |
FDA Impact on Med Tech Innovation Study (Slide Deck, White Paper and NVCA Statement) |
| Nov 3 |
Election Analysis: Impact on Venture Community |
| Oct 8 |
NVCA Supports ARPA-E Innovation Summit |
| Sept 21 |
Global VC Congress Urges Europe to Protect SME’s from AIFM Directive |
| Sept 8 |
NVCA Launches Medical Innovation and Competitiveness (MedIC) Coalition |
| Sept 7 |
NVCA Comment Letter on Fair Value Measurement, September 2010 |
| Aug 30 |
NVCA Director Rothrock Testifies Before Commission on America's Nuclear Future |
| July 26 |
Revised Campaign Contribution Policy and Investment Advisors Act Rule Summary |
| July 21 |
NVCA Statement on Venture Capital and the Treatments and Cures of Pediatric Diseases |
| July 20 |
NVCA's Comments on FDA's Transparency Initiative |
| June 29 |
Letter to President in Support of Clean Energy Deployment Administration (CEDA) |
| June 22 |
Proskauer Rose Alert on AIFM Directive |
| June 16 |
NVCA Expresses Support for Small Business Lending Act |
| June 16 |
NVCA Applauds President’s Call to Accelerate Clean Energy Economy |
| June 14 |
NVCA Comment Letter on CalPERS Proposed Placement Agent Rules June, 2010 |
| June 10 |
NVCA Testifies on Improving Technology Transfer |
| June 10 |
Council for Medical Innovation Releases Important Study |
| June 9 |
NVCA Releases Paper on the Impact of Health Reform on Innovation |
| May 28 |
NVCA Letter to Senate Regarding Patent Reform Compromise |
| May 28 |
House Discourages Job Creation With Passage of HR 4213 |
| May 26 |
Mr. President: Academics Oppose Higher Carried Interest Tax |
| May 20 |
NVCA Statement on HR 421 |
| May 18 |
1400+ Entrepreneurs Urge Congress to Preserve Cap Gains Incentive for VC Carried Interest (Letter) |
| May 13 |
Letter to Chairman Levin: Protect Michigan, Protect Venture Capital |
| May 11 |
5 US Senators Support Cap Gains for VC Carried Interest |
| May 11 |
More Than 1700 Urge Senate to Protect VC Carried Interest (Letter) |
| Apr 27 |
Carried Interest Taxation Debate: Latest Developments & Frequently Asked Questions |
| Apr 21 |
Support for ARPA-E Funding - Press Release and Letter |
| Apr 21 |
Venture Backed StartUps Add Jobs in Q1 |
| Apr 15 |
NVCA Support Letter for Cures Acceleration Network (CAN) |
| Apr 9 |
NVCA Warns of Ramifications of AB 32 Delay in CA |
| Apr 7 |
Green Bank’s Role in Energy Transformation |
| Apr 5 |
Model Campaign Contributions Policy to Comply with SEC Proposed Rule 206(4)-5 |
| Mar 24 |
NVCA Member Paul Holland House Testimony: Supporting Innovation in the 21st Century Economy |
| Mar 9 |
NVCA Letter of Support for Broadband Access |
| Mar 2 |
NVCA/ACA Letter Regarding Financial Stability Act of 2009 |
| Mar 1 |
NVCA Statement Regarding 510(k) Review Process |
| Feb 25 |
NVCA Applauds Startup Visa Act |
| Feb 24 |
NVCA Recognizes Congresswoman Anna Eshoo as a Champion of Innovation With The American Spirit Award for 2010 |
| Feb 23 |
NVCA Statement to Senate Finance Committee on Small Business Tax Issues relating to Small Business |
| Jan 22 |
NVCA Letter to FDA Regarding Novel Therapies and Technologies - January 2010 |
| Jan 21 |
Senate CEDA Legislation Would Create Jobs |
| Jan 8 |
NVCA Letter to White House Regarding Health Care Reform, January 2010 |
| Jan 8 |
NVCA Supports First Ever ARPA-E Energy Innovation Summit |
| Jan 7 |
NVCA Comment letter to FASB about Consolidation of Financial Statements – January 2010 |
| |
2009 |
| Dec 9 |
House of Representatives Penalizes Job Creators to Pay for Year End Tax Extensions |
| Dec 3 |
NVCA Members Invited to President Obama’s Job & Economic Growth Forum |
| Nov 10 |
VC Industry Applauds Exemption Language in Senate Financial Reform Legislation |
| Nov 5 |
NVCA Urges Senate to Pass Clean Energy Jobs Act |
| Oct 15 |
Letters to Congress on Proposed Tax on Medical Device Sector |
| Oct 14 |
NVCA testifies on Access to Capital for Small Businesses |
| Oct 8 |
NVCA Comment Letter Regarding FASB Fair Value Measurement and Disclosure |
| Oct 6 |
NVCA Chairman Terry McGuire Testifies in Support of Private Fund Investment Advisers Registration Draft (Written Testimony, Oral Testimony) |
| Oct 1 |
NVCA Comment Letter on Proposed Restrictions on Political Contributions by Certain Investment Advisors |
| Oct 1 |
NVCA Applauds Venture Capital Exemption Language in Draft of Investment Advisers Act |
| Sept 23 |
NVCA Member, Trevor Loy, testifies on Capitol Hill on impact on small business from proposed financial system reforms |
| July 29 |
NVCA Testifies on IP Protection in the Cleantech Sector |
| July 28 |
Background on Investment Adviser Registration |
| July 15 |
Congressional testimony on regulation of hedge funds and private investment pools |
| July 14 |
NVCA Congressional Testimony on Follow-on Biologics |
| July 10 |
Cost of Capital for Early Stage Biotech Start-Ups Found to be in Excess of 20 Percent (Presentation, Executive Summary) |
| June 17 |
NVCA Response to President Obama's Plan for Financial System Regulation Reform |
| June 4 |
NVCA Testimony on Strengthening the SBIR Program |
| May 12 |
NVCA's Statement Regarding the Impact of the Medical Device Safety Act |
| Apr 29 |
NVCA Makes Recommendations to Address Capital Markets Crisis (Presentation Slideshow)
|
| Apr 22 |
NVCA Testimony Regarding the SBIR Program |
| Mar 26 |
NVCA Testimony: Expanding Equity Investment in Small Businesses - (Release or Testimony) |
| Mar 24 |
VC Industry Joins President in Support of Clean Technology |
| Mar 12 |
Energy Provisions in Economic Stimulus Bill |
| Feb 12 |
NVCA testimony to Senate Committee on DOE Loan Guarantee Program |
| Feb 10 |
NVCA Submits Comments on Patent Reform |
| Feb 3 |
VC's Call For Focus on Job Creation and Economic Growth in SBIR Program |
| Jan 21 |
NVCA Submits Letter to Congress in Support of R&D Funding |
| |
|
· 
· 
· 
·
